Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Lohray

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|September 24, 2004
Advances in insulin sensitizersB B Lohray, Vidya Bhushan
Bioorganic & Medicinal Chemistry Letters|May 3, 2006
3D QSAR studies of N-4-arylacryloylpiperazin-1-yl-phenyl-oxazolidinones: a novel class of antibacterial agentsB B Lohray, Neha Gandhi, Brijesh Kumar Srivastava, et al.
Arzneimittel-Forschung|March 20, 1999
Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar ratsH K Jajoo, R N Mamidi, S V Vakkalanka, et al.
Arzneimittel-Forschung|December 22, 1999
Studies on the euglycemic and hypolipidemic potentials of the novel indole analogue of thiazolidinedione, DRF 2189R Chakrabarti, R K Vikramadithyan, T Dileepkumar, et al.
Journal of Medicinal Chemistry|July 20, 1999
Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinedionesB B Lohray, V Bhushan, A S Reddy, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Novel quinolone derivatives as potent antibacterialsB B Lohray, S Baskaran, B S Rao, et al.
Journal of Medicinal Chemistry|July 27, 2001
(-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activityB B Lohray, V B Lohray, A C Bajji, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motifK A Reddy, B B Lohray, V Bhushan, et al.
Journal of Medicinal Chemistry|August 28, 1999
Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivativesK A Reddy, B B Lohray, V Bhushan, et al.
European Journal of Medicinal Chemistry|October 16, 2001
Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agentsG R Madhavan, R Chakrabarti, S K Kumar, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|September 24, 2004
Advances in insulin sensitizersB B Lohray, Vidya Bhushan
Bioorganic & Medicinal Chemistry Letters|May 3, 2006
3D QSAR studies of N-4-arylacryloylpiperazin-1-yl-phenyl-oxazolidinones: a novel class of antibacterial agentsB B Lohray, Neha Gandhi, Brijesh Kumar Srivastava, et al.
Arzneimittel-Forschung|March 20, 1999
Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar ratsH K Jajoo, R N Mamidi, S V Vakkalanka, et al.
Arzneimittel-Forschung|December 22, 1999
Studies on the euglycemic and hypolipidemic potentials of the novel indole analogue of thiazolidinedione, DRF 2189R Chakrabarti, R K Vikramadithyan, T Dileepkumar, et al.
Journal of Medicinal Chemistry|July 20, 1999
Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinedionesB B Lohray, V Bhushan, A S Reddy, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Novel quinolone derivatives as potent antibacterialsB B Lohray, S Baskaran, B S Rao, et al.
Journal of Medicinal Chemistry|July 27, 2001
(-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activityB B Lohray, V B Lohray, A C Bajji, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motifK A Reddy, B B Lohray, V Bhushan, et al.
Journal of Medicinal Chemistry|August 28, 1999
Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivativesK A Reddy, B B Lohray, V Bhushan, et al.
European Journal of Medicinal Chemistry|October 16, 2001
Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agentsG R Madhavan, R Chakrabarti, S K Kumar, et al.
Pageof 2